{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:22:03Z","timestamp":1750537323873},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 66-year-old man with follicular thyroid cancer after total thyroidectomy was referred for <jats:sup>131<\/jats:sup>I therapy. Thyroid function tests before <jats:sup>131<\/jats:sup>I administration exhibited severe thyrotoxicosis although the patient did not take levothyroxine after thyroidectomy. A 185 MBq <jats:sup>131<\/jats:sup>I whole-body scintigraphy and SPECT\/CT revealed multiple iodine-avid pulmonary metastases with the largest tumor diameter of 1.4 cm and remnant thyroid. A diagnosis of thyrotoxicosis caused by hyperfunctioning pulmonary metastases was then made. The patient was administered 7.4 GBq of <jats:sup>131<\/jats:sup>I. Six months after <jats:sup>131<\/jats:sup>I therapy, a significant reduction of the pulmonary metastatic disease and thyroglobulin level was observed. However, the remnant thyroid was still visualized.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002477","type":"journal-article","created":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T22:41:29Z","timestamp":1549147289000},"page":"327-329","source":"Crossref","is-referenced-by-count":3,"title":["Remarkable Response of Pulmonary Metastases Rather Than Remnant Thyroid in 131I Therapy of Follicular Thyroid Cancer"],"prefix":"10.1097","volume":"44","author":[{"given":"Tian","family":"Tian","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhao","family":"Xiang","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Liu","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00003072-200502000-00001","article-title":"Metastatic follicular carcinoma associated with hyperthyroidism","volume":"30","year":"2005","journal-title":"Clin Nucl Med"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2967\/jnumed.107.041202","article-title":"Uncommon causes of thyrotoxicosis","volume":"49","year":"2008","journal-title":"J Nucl Med"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1089\/thy.2011.0437","article-title":"Euthyroid status after total thyroidectomy due to functioning lung metastases from a clear cell variant of papillary thyroid carcinoma","volume":"22","year":"2012","journal-title":"Thyroid"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4158\/EP161431.OR","article-title":"Death related to pulmonary metastasis in patients with differentiated thyroid cancer","volume":"23","year":"2017","journal-title":"Endocr Pract"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1515\/jpem-2018-0075","article-title":"Detection of distant metastasis at the time of ablation in children with differentiated thyroid cancer: the value of pre-ablation stimulated thyroglobulin","volume":"31","year":"2018","journal-title":"J Pediatr Endocrinol Metab"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cen.13158","article-title":"Is post-ablation whole body 131I scintigraphy still necessary in intermediate-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin < 1 ng\/mL?","volume":"86","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/RLU.0000000000001426","article-title":"Evaluation of prognostic factors associated with differentiated thyroid carcinoma with pulmonary metastasis","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/RLU.0000000000000507","article-title":"Long-term survival and low effective cumulative radioiodine doses to achieve remission in patients with 131-iodine-avid lung metastasis from differentiated thyroid cancer","volume":"39","year":"2014","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201904000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:15:18Z","timestamp":1695618918000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201904000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002477","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}